Acute necrotizing ulcerative gingivitis

AB1_ANUG_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — A69.10 Hospital discharge: ICD-10 — A69.10 Cause of death: ICD-10 — A69.10 3 out of 7 registries used, show all original rules.	53
4. Check minimum number of events None	53
5. Include endpoints None	53
6. Filter based on genotype QC (FinnGen only)	50

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF13

NAME	AB1_ANUG_WIDE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	A6910
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A6910
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A6910
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acute necrotizing ulcerative gingivitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Acute necrotizing ulcerative gingivitis

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	50	34	16
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	35.86	33.42	41.05

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
53: Matched controls
530

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A69.10

ICD-10 Finland

Acute necrotizing ulcerative gingivitis (ANUG)

+∞

75.9

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

5.0

7.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044640) Blood type and Crossmatch panel - Blood

120

2.83

3.30

2.0

2.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2.85

2.96

2.2

2.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3.10

2.90

3.3

4.2

0.79

0.82

mmol/l

0.72

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3.31

2.87

2.1

2.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

325

3.08

2.82

4.2

3.8

14.66

14.63

pmol/l

0.02

298

(3028707) Methadone [Presence] in Urine by Screen method

4.76

2.80

1.9

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3.86

2.78

2.1

1.4

—

(3019225) pH of Specimen

4.12

2.72

2.7

6.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3.73

2.69

2.0

1.4

—

(3000991) Gas panel - Venous blood

4.09

2.48

6.3

17.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2.35

2.07

2.8

2.6

—

(3042936) Bacteria identified in Isolate by Culture

2.69

2.05

2.3

3.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

4.89

1.98

1.2

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

4.89

1.98

1.2

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.00

1.81

0.0

1.5

—

(3011288) Drugs identified in Urine by Screen method

2.95

1.81

2.4

1.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.70

1.73

7.0

10.4

101.70

105.50

mmol/l

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

135

2.08

1.72

10.4

10.0

1.22

mmol/l

0.04

127

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

128

2.06

1.67

1.7

87.67

96.50

pmol/l

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

137

2.04

1.64

2.0

3.5

26.36

30.05

u/l

0.49

129

(3009508) Creatinine [Moles/volume] in Urine

2.11

1.59

4.6

2.9

7.88

8.28

mmol/l

0.15

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

156

1.98

1.58

2.0

1.8

—

(40758558) Short blood count panel - Blood

2.06

1.50

5.7

6.2

—

(3013115) Eosinophils [#/volume] in Blood

205

1.92

1.47

7.6

4.8

0.19

0.17

e9/l

0.25

191

(3016879) Cocaine [Presence] in Urine

2.43

1.46

2.0

1.2

—

(3000492) Spirometry study

2.37

1.42

1.3

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2.81

1.41

9.0

15.7

0.85

0.75

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2.81

1.41

1.7

1.3

—

(3027008) Opiates [Presence] in Urine

2.26

1.35

2.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

2.26

1.35

2.1

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2.69

1.34

8.2

15.1

1.47

1.66

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2.57

1.28

9.0

14.5

83.52

92.59

—

(3001604) Monocytes [#/volume] in Blood

203

1.80

1.26

7.6

4.3

0.55

0.54

e9/l

0.05

186

(3006315) Basophils [#/volume] in Blood

203

1.80

1.26

7.6

4.3

0.04

e9/l

0.30

186

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.30

1.25

2.1

1.2

—

(3003396) Base excess in Arterial blood by calculation

2.30

1.25

7.4

23.3

1.52

1.45

mmol/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

194

1.80

1.24

8.2

4.6

—

(3019198) Lymphocytes [#/volume] in Blood

215

1.77

1.19

8.1

4.3

2.24

1.91

e9/l

0.95

202

(3000764) Benzodiazepines [Presence] in Urine

2.20

1.12

2.0

1.2

—

(3027944) Amphetamines [Presence] in Urine

2.20

1.12

1.9

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

219

1.72

1.08

7.5

4.0

0.00

estimate

—

(3019060) Gas panel - Arterial blood

2.40

1.05

5.0

24.1

—

(3009261) Glucose [Presence] in Urine by Test strip

221

1.69

1.03

4.9

2.9

0.00

estimate

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

139

1.70

0.99

2.7

2.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

105

1.75

0.96

1.9

3.2

56.69

54.03

u/l

0.18

(3005719) IgG [Mass/volume] in Serum or Plasma

2.28

0.95

4.7

1.4

10.10

11.07

g/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

132

0.54

0.89

7.9

2.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

412

1.88

0.80

17.2

13.2

139.57

139.60

mmol/l

0.06

401

(3044889) 12 lead EKG panel

251

1.57

0.79

3.1

2.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

415

1.82

0.79

17.0

13.2

3.91

3.92

mmol/l

0.12

402

(3023368) Bacteria identified in Blood by Culture

1.70

0.78

5.7

4.7

—

(3022621) pH of Urine by Test strip

1.97

0.77

9.1

2.1

—

(3018095) Leukocytes [#/volume] in Urine

138

1.59

0.77

6.6

3.4

148.43

61.98

e6/l

0.32

(3031040) Bacteria [#/volume] in Urine by Automated count

283

1.56

0.76

6.1

4.0

—

75.50

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

440

1.96

0.75

17.9

11.3

19.34

22.41

mg/l

0.32

332

(3013512) EKG study

1.70

0.73

3.2

3.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

149

1.55

0.72

3.6

2.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

100

0.55

0.71

2.2

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1.94

0.70

18.6

7.9

7.52

7.06

mmol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

198

1.50

0.68

3.3

3.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

397

1.64

0.62

14.2

10.1

99.18

96.00

ml/min/173m2

0.30

316

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

108

1.54

0.62

1.9

3.1

20.20

24.29

ng/l

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1.60

0.62

1.5

2.7

2031.13

801.28

ng/l

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

250

1.46

0.61

10.8

7.0

4.27

4.02

e9/l

0.21

222

(3013826) Glucose [Moles/volume] in Serum or Plasma

222

1.44

0.58

5.3

7.1

6.11

6.21

mmol/l

0.20

197

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.70

0.58

2.7

2.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.56

0.53

1.5

1.4

—

(3021589) Normoblasts [#/volume] in Blood

196

1.41

0.53

10.6

6.3

0.00

e9/l

-0.00

159

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.51

0.52

2.5

2.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

197

1.40

0.51

2.7

2.1

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

131

1.44

0.50

5.1

3.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.53

0.49

1.4

1.7

—

(3002256) Pathology report gross observation

1.53

0.49

1.3

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.52

0.48

1.8

2.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.67

0.44

2.0

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.57

0.42

1.0

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.57

0.42

1.2

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.57

0.42

1.2

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.57

0.42

1.2

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.57

0.42

1.2

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.42

0.0

1.3

—

(3000494) Fungus identified in Specimen by Culture

1.47

0.40

1.0

1.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.43

0.39

2.8

2.4

—

(1761868) Lipid panel - Serum or Plasma

163

0.73

0.36

2.5

2.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

295

1.31

0.36

4.8

4.0

—

(36304419) Bacteria [Presence] in Urine

102

1.36

0.34

7.0

2.7

—

(3035350) Ketones [Presence] in Urine by Test strip

217

1.29

0.33

4.5

2.9

0.00

estimate

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.34

0.29

2.5

1.6

—

(3026782) Osmolality of Urine

1.28

0.27

6.0

2.4

563.44

544.66

mosm/kgh2o

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

166

0.79

0.25

5.6

2.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.35

0.24

1.0

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.31

0.23

1.6

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.00

0.21

0.0

1.4

—

206.82

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

0.00

0.21

0.0

1.6

—

8.64

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.21

0.0

1.8

—

7.73

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.21

0.0

1.6

—

6.83

—

(40768443) Skin Pathology biopsy report

0.00

0.20

0.0

1.3

—

(3003694) ABO and Rh group [Type] in Blood

168

1.20

0.19

2.2

1.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.15

0.18

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

134

1.17

0.12

2.4

1.8

—

(3026008) Bacteria identified in Urine by Culture

125

1.16

0.11

3.9

2.4

—

(36660697) Celiac disease serology panel - Serum

1.07

0.10

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

1.09

0.08

1.0

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.79

0.08

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

391

1.09

0.04

3.7

4.0

—

(3002385) Erythrocyte distribution width [Ratio]

398

0.92

0.03

17.7

13.9

13.26

13.96

1.71

392

(3007164) IgA [Mass/volume] in Serum or Plasma

103

1.09

0.02

2.0

1.3

1.77

2.46

g/l

—

(40768804) Tissue Pathology biopsy report

174

1.05

0.00

1.9

—

(3029937) Albumin [Presence] in Urine by Test strip

118

1.02

0.00

2.8

3.0

0.00

estimate

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.0

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

0.00

0.0

1.3

—

0.84

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

0.0

2.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

0.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.00

0.0

1.9

—

24.29

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

1.33

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

0.00

-0.00

0.0

2.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

150

1.00

-0.00

2.7

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

-0.00

0.0

1.3

—

(3003181) Sodium [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

69.60

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3021901) Oxygen saturation in Capillary blood

0.00

-0.00

0.0

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

0.00

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

1.1

—

91.90

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.8

—

1.82

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

106.07

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

9.3

—

762.57

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

0.00

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

3.2

—

13.80

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

0.00

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

0.96

-0.00

5.4

2.3

5.40

6.61

e6/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.02

-0.00

2.0

2.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

10.1

—

1483.86

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_ANUG_WIDE – Acute necrotizing ulcerative gingivitis

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Acute necrotizing ulcerative gingivitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Acute necrotizing ulcerative gingivitis (AB1_ANUG_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints